Abstract: A process for manufacturing aloe gel from the leaves of the Aloe vera plant, comprising the following steps: cleaning each leaf; hand filleting each aloe leaf to separate the internal gel and leaving behind leaf residue; collecting the internal gel in a stainless steel container; Milling the gel in a multimill to obtain gel having particle size less than 1.5 mm; adding charcoal in the range of 1% of the mass of the gel in particle size greater than 1.5 mm and mixing it well with the juice and pasteurizing the gel by heating the gel to about 70 to 75 degrees C. for about half an hour and; prefiltering the juice to remove the charcoal; adjusting the pH of the juice to lie on the range of 3.5 to 4 using lemon juice; finally filtering of the pH adjusted juice using a filter bed and nutch filtration to remove even trace fibers from the juice; filling the fiber free filtered juice in sterilized bottles and air tight sealing of the bottles; autoclaving the sealed bottles in an autoclave at about 121° C.

Abstract: A Kampo medicinal extract-containing tablet composition contains a Kampo medicinal extract powder, cellulose glycolate and sodium hydrogen carbonate. It preferably further contains silicic anhydride. A process to manufacture a Kampo medicinal extract-containing tablet composition by the step of adding silicic anhydride and water to a Kampo medicinal extract powder, stirring and granulating the mixture, and the step of mixing the granulated substance with cellulose glycolate and sodium hydrogen carbonate. The Kampo medicinal extract-containing tablet composition can be satisfactorily disintegrated and dissolved and a process for manufacturing the same, by formulating specific compounds to a Kampo medicinal extract powder.

Abstract: Disclosed is a composition comprising extracts of Radix Clematidis for preventing and treating diabetes, diabetic complications, insulin resistance and insulin resistance syndrome. The composition of the present invention for preventing and treating diabetes, diabetic complications, insulin resistance and insulin resistance syndrome, comprises extracts of Radix Clematidis in an amount of 0.5-50 wt % based on the total composition weight.

Abstract: A cigarette/tea system has a quantity of herbal plant leaves and other herbal plant parts including pulmonaria officinalia and tussilago farfara and agrimonia eupatonia and petasites hybridus and hamamelis virginiana and tropaeolum majus.

Abstract: Methods and compositions for treating diseases mediated by CB2 receptors are disclosed, including fibrosis associated with liver injury.

Abstract: This invention relates to a composition of the plant Withania Somnifera, and, more particularly to a high purity extract composition with advantageous levels of withanolide glycosides and oligosaccharides, a minimum of polysaccharides, and substantially low levels of free withaferin A and equivalents (withanolide aglycones), which composition provides enhanced cognition-enhancing effects for the user, and an extraction process for obtaining such composition, as well as pharmaceutical, nutritional and personal care use products thereof.

Abstract: The invention discloses a medicine that can treat CRF and the preparation method of it, which mainly make up of fleece-flower root, dodder, pseudostellaria root, atractylodes rhizome, wolfberry fruit, Achyranthes root the invented medicine absorb quickly, have good curative effect, with high content of effective component and admit is convenience.

Abstract: The present invention relates to an agent that suppresses appetite and provides quick energy. According to at least one aspect of the present invention, a lollipop is provided that suppresses appetite and provides quick energy. The lollipop is made from a premixed herbal formula that is combined with a hard candy confection base. The herbal premixed formula includes the following active ingredients: Guarana PE 22%; CitriMax®; and L-Tyrosine. The herbal premix formula can also include Vitamin B6; and Vitamin B12 Cyanacobalamin. The premixed formula is added to a candy base that may include corn syrup, Maltodextrin, sugar, natural color and natural flavorings.

Abstract: The invention features methods of reducing the level of a ?-amyloid (A?) polypeptide using an Cimicifuga extract. The invention also features methods of producing an active fraction from an extract of Cimicifuga. The invention further features a composition containing an active fraction of a Cimicifuga extract and an article of manufacture containing such a composition.

Abstract: The present invention discloses a medicament useful for treating aseptic inflammations, containing anemonin as an effective ingredient, and use of the anemonin compound in treating aseptic inflammations. The effective ingredient in the present medicament, anemonin, can be extracted and separated from natural plants containing anemonin or its precursor. The present invention also discloses a method for preparing anemonin extract. The present medicament can be formulated into preparations for oral administration, injection and topical application, especially liquid extract, plaster, suppository, liniment, and paint etc., which can be transdermally absorbed.

Abstract: The present invention relates to herbal compositions useful for the treatment of patients with diseases or disorders characterized by having a fibrotic component.

Abstract: The present invention comprises methods for making compositions derived from Ilex species, particularly Ilex paraguariensis, having lowered caffeine and tannin concentrations, compositions made by such methods, oral delivery formulations, and methods of use of such compositions. In particular, the present invention comprises methods for making maté compositions that have a predetermined characeteristic, such as a lowered amount of caffeine, elevated amounts of caffeoyls, and/or lowered amounts of tannin compounds compared to the native maté plant materials. Further, the invention comprises methods of additional processing steps tp produce compositions having a predetermined alkaloid ratio or profiles to meet particular considerations for final products. The compositions of the present invention may be processed for specific uses such as tablets or other oral delivery vehicles. These compositions may be used in methods for treatment of physiological and medical conditions.

Abstract: A dietary supplement comprising as its active ingredients soybean, mushroom and mung bean is used in a method to in a method to ameliorate at least one effective malignancy or viral infection or to enhance immune functions. The active components of the dietary supplement include phytoestrogens, ?-glucans, saponins, inositol hexaphosphate, and lectins.

Abstract: The present invention comprises methods for making compositions derived from Ilex species, particularly Ilex paraguariensis, having lowered caffeine and tannin concentrations, compositions made by such methods, oral delivery formulations, and methods of use of such compositions. In particular, the present invention comprises methods for making maté compositions that have a predetermined characeteristic, such as a lowered amount of caffeine, elevated amounts of caffeoyls, and/or lowered amounts of tannin compounds compared to the native maté plant materials. Further, the invention comprises methods of additional processing steps to produce compositions having a predetermined alkaloid ratio or profiles to meet particular considerations for final products. The compositions of the present invention may be processed for specific uses such as tablets or other oral delivery vehicles. These compositions may be used in methods for treatment of physiological and medical conditions.

Abstract: The present invention provides a preparation for treatment or prevention of a condition in a patient, said preparation comprising Schisandrin B. The concentration of Schisandrin B in the preparation may be between about 0.01 and about 0.1%, or it may be between about 20 and about 40% w/w or w/v. The preparation may additionally comprise one or more components selected from the group consisting of herbal extracts, fluids, solvents, antioxidants, preservatives, electrolytes, salts and pH control agents.

Abstract: A method for removing aflatoxins from Chinese herbal medicines comprises the steps of grinding a predetermined Chinese herbal medicine and submerging it into an amount of alcohol solvent twice as much as the dry weight of the medicine and using water to flush away the alcohol solvent from the medicine after a being submerged for a predetermined period of time. The Chinese herbal medicine is then dried to reduce its water content. The above steps are repeated at least twice so as to reduce its aflatoxins under a safety level.

Abstract: A recipe of Chinese herbal composite used in horticulture to kill pests. The practical applications of this recipe include pest killing, germ and virus eradication of vegetables, fruit trees, flowers and economical plants. This recipe is composed of Gleditisia Sinensis, Sophora flavescens, Aloe vera, Stemona tuberosa, Brucea javanica and Dioscorea collettis vice versa. We prepare it with modern principles and scientific methods to emulsion spray. Those so called modern and scientific are the emulsion processes, micronization, permeability and the multiply potency it possessed. Several laboratory and field test proved that this invention had definite effect on the past killing, germ eradiation and virus inhibition. This invention is belongs to non toxic Chinese herbal preparation. The spray does not harm or cause toxic effect as it touch human skin, eyes, nasal mucosa, lip, mouth and tongue. It does not accumulate in human body and pollute environment.

Abstract: A method of using guava extract is disclosed that includes administering alcohol to a mammal, and administering guava extract within no greater than about 12 hours of administering of the alcohol. A composition is also disclosed that includes a pharmaceutically acceptable carrier and guava extract.

Abstract: An elixir combining synergistic components, all of which are derived from the same source, namely almond hulls.

Abstract: The invention relates to the use of an extract of the alga Phaeodactylum, particularly the alga Phaeodactylum tricornutum, as a cosmetic agent promoting the proteasome activity of skin cells, particularly keratinocytes, fibroblasts or melanocytes (preferably human). The invention makes it possible to manufacture a cosmetic composition for protecting the skin from the adverse effects of UV exposure or for preventing and/or delaying skin ageing effects.